With venture capital funding of digital health up 45 percent in 2012, according to Rock Health, we're hearing a lot about mobile health apps and healthcare IT. You may be asking yourself what is digital health? Hear my take on…more
Recently, the Pew Internet & American Life Project (the “Pew Internet Report”) reported that nearly 70% of Americans are monitoring one or more health metrics for themselves or a loved one, but only 21% of those are using a…more
The New York Times’ health and science blog, Well, recently published a post discussing the results of an informal quest to find the price of a hip transplant. The post received widespread attention and commentary because of its…more
The question of whether or not smartphone apps can play an important role in the delivery of healthcare services has been more or less answered with a resounding yes. From weight loss to diabetes monitoring to diagnosing ear…more
According to a recent report released by Rock Health, Big Data has the potential to save the healthcare system more than $300 billion per year by improving poorly coordinated care, reducing fraud and abuse, and improving…more
The Federal Trade Commission (FTC or Commission) recently published a guide, Marketing your Mobile App: Get it Right From the Start, to help mobile app developers understand FTC advertising and privacy rules…more
On October 5, the United States Supreme Court agreed to review the case Bowman v. Monsanto Co., Docket No. 11-796 (USSC 2012). The high court will be taking on the question of patent exhaustion in seeds, specificallyMonsanto's…more
Times are tough in the life science financing environment, as underscored by numerous recent news stories as well as quarterly statistics from Dow Jones VentureSource and The MoneyTree Report…more
Survey Introduction and Background -
For the past ten years, Fenwick & West has published a quarterly survey of trends in the valuations and terms of venture financings in Silicon Valley. A copy of the most recent version…more
Two recent conflicting Federal Circuit cases (Classenand Momenta) interpreting the Hatch-Waxman safe harbor provision (35 USC 271(e)(1)) have stirred debate in the biosimilars community…more
From the minute you stepped off the elevator at Rock Health’s annual Health Innovation Summit on Tuesday, there was an undeniable energy. The sold out event was jam-packed with entrepreneurs, investors and health and technology…more
The New York Times recently ran a story titled, “It’s hard to stay friends with an exercise monitor” that underscored a problem facing many health and fitness apps – the risk that users quickly lose interest.
…more
The August 2012 decision in Momenta Pharmaceuticals v. Amphastar Pharmaceuticals, Inc. has expanded the “safe harbor” provisions of Hatch-Waxman, with serious implications for the pharma and biotech industries…more
We've known for some time that the pharma patent cliff was driving M&A, and now we have additional empirical evidence. Biotech M&A is at a 5 year high, according to Reuters. The volume of biotech M&A is more than $25 billion so…more
On Thursday United States Patent and Trademark Office (USPTO) Director David Kappos announced the Global Dossier Initiative, which aspires to be a "global portal for all stakeholders working on patent filings in multiple patent…more
This profile may constitute attorney advertising. Prior results do not guarantee a similar outcome. Any correspondence with this profile holder does not constitute a client/attorney relationship. Neither the content on this profile nor transmissions between you and the profile holder through this profile are intended to provide legal or other advice or to create an attorney-client relationship.
